{"cord_uid": "mwchd209", "sha": "", "source_x": "WHO", "title": "Maintaining Blood Glucose Levels in Range (70\u2013150 mg/dL) is Difficult in COVID-19 Compared to Non-COVID-19 ICU Patients\u2014A Retrospective Analysis", "doi": "", "pmcid": "", "pubmed_id": "", "license": "unk", "abstract": "Beta cell dysfunction is suggested in patients with COVID-19 infections Poor glycemic control in ICU is associated with poor patient outcomes This is a single center, retrospective analysis of 562 patients in an intensive care unit from 1 March to 30 April 2020 We review the time in range (70&ndash;150 mg/dL) spent by critically ill COVID-19 patients and non-COVID-19 patients, along with the daily insulin use Ninety-three in the COVID-19 cohort and 469 in the non-COVID-19 cohort were compared for percentage of blood glucose TIR (70&ndash;150 mg/dL) and average daily insulin use The COVID-19 cohort spent significantly less TIR (70&ndash;150 mg/dL) compared to the non-COVID-19 cohort (44 4% vs 68 5%) Daily average insulin use in the COVID-19 cohort was higher (8 37 units versus 6 17 units) ICU COVID-19 patients spent less time in range (70&ndash;150 mg/dL) and required higher daily insulin dose A higher requirement for ventilator and days on ventilator was associated with a lower TIR Mortality was lower for COVID-19 patients who achieved a higher TIR", "publish_time": "2020", "authors": "Kapoor, Rajat Timsina Lava R.; Gupta, Nupur Kaur Harleen Vidger Arianna J.; Pollander, Abby M.; Jacobi, Judith Khare Swapnil Rahman Omar", "journal": "Journal of Clinical Medicine", "mag_id": "", "who_covidence_id": "#918936", "arxiv_id": "", "pdf_json_files": [""], "pmc_json_files": [""], "url": "", "s2_id": "226990974"}